4Hiromatsu Y, Damu Y, Ikuyo M, et al. Nicotinamide decreases cytokine-induced activation of orbital fibroblasts from patients with thyroid-associated ophthalmopathy [J]. J Clin Endocrinol Metab , 1998,83(1) .. 121-124.
3N Otte, C Borelli, HC Korting. Nicotinamide biologic actions of an emerging cosmetic ingredient[J]. Int J Cosmet Sci, 2005, 27 (5):255-261.
4Hiromatsu Y, Sato M, Tanaka K, et al. Inhibitory effects of nicotinamide on intercellular adhesion molecule-1 expression on cultured human thyroid cells [J]. Immunology, 1993, 80 ( 2 ) : 330-332.
5JS Ungerstedt, M Blomback, T Soderstrom. Nicotinamide is a potent inhibitor of proinflammatory cytokines[J]. Clin Exp Immunol, 2003,131 ( 1 ) : 48-52.
6Bernstein JE, Lorincz AL. The effects of topical nicotinamide, tetracycline,and dapsone on potassium iodide induced inflam mation[J]. J Invest Dermatol, 1980,74: 257-258.
7Donald L,John E, Abel S, et al. Topical niacinamide provides skin aging appearance benefits while enhancing battier function [J]. Journal of Clininal Dermatology, 2003,32 : s9-s18.
8ZD Draelos, A Matsubara, K Smiles. The effect of 2% niacinamide on facial sebum production[J]. J Cosmet Laser Ther, 2006,8(2) :96-101.
9W Gehring. Nicotinic acid/niacinamide and the skin[J]. J Cosmet Dermatol,201)4,3(2):88-93.
10AR Shalita, JG Smith, LC Parish, et al. Topical nicotinamide compared with clidamycin Gel in the treatment of inflammatory acne vulgaris[J]. Int J Dermatology, 1995,34(6) :434-437.
